APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Pathology Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Pathology Platform Market Outlook and Growth Opportunities 2026

1 May 2026191 pages

Choose your research edition.

Industry ResearchDigital Pathology Platform Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Pathology Platform Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Digital Pathology Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Pathology Platform Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Pathology Platform Market Analysis and Forecast 2026-2032238 pages · $4,950 USD

Market perspective

The global Digital Pathology Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Pathology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Pathology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Pathology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Pathology Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Pathology Platform market include Leica Biosystems, Olympus, Philips, Roche, 3DHISTECH, Hamamatsu Photonics, ZEISS, OptraScan and Media Cyber​​netics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Pathology Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Pathology Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Pathology Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Pathology Platform market.

Digital Pathology Platform Segment by Company

Leica Biosystems

Olympus

Philips

Roche

3DHISTECH

Hamamatsu Photonics

ZEISS

OptraScan

Media Cyber​​netics

Visiopharm

Sectra

Digital Slide Archive

Aiforia

PathAI

Pathomation

Proscia

Indica Labs

Gestalt

Xybion

NovoPath

Glencoe Software

Orbit Image Analysis

Augmentiqs

Digital Pathology Platform Segment by Type

Open-Source Platforms

Closed-Source Platforms

Digital Pathology Platform Segment by Application

Pharmaceutical

Clinical Use

Research

Education

Digital Pathology Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Pathology Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Pathology Platform key companies, revenue, market share, and recent developments.

3. To split the Digital Pathology Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Pathology Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Pathology Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Pathology Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Pathology Platform industry.

Chapter 3: Detailed analysis of Digital Pathology Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Pathology Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Pathology Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Pathology Platform Industry Trends Table 2. Digital Pathology Platform Industry Drivers Table 3. Digital Pathology Platform Industry Opportunities and Challenges Table 4. Digital Pathology Platform Industry Restraints Table 5. Global Digital Pathology Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Pathology Platform Revenue Share by Company (2021-2026) Table 7. Global Digital Pathology Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Pathology Platform Key Company Manufacturing Base & Headquarters Table 9. Global Digital Pathology Platform Company, Product Type & Application Table 10. Global Digital Pathology Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Pathology Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Open-Source Platforms Table 15. Significant Companies of Closed-Source Platforms Table 16. Global Digital Pathology Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Digital Pathology Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Digital Pathology Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Digital Pathology Platform Sales Value Share by Type (2021-2026) Table 20. Global Digital Pathology Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Table 22. Significant Companies of Clinical Use Table 23. Significant Companies of Research Table 24. Significant Companies of Education Table 25. Global Digital Pathology Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digital Pathology Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Digital Pathology Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Digital Pathology Platform Sales Value Share by Application (2021-2026) Table 29. Global Digital Pathology Platform Sales Value Share by Application (2027-2032) Table 30. Global Digital Pathology Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Pathology Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Digital Pathology Platform Sales Value Share by Region (2021-2026) Table 33. Global Digital Pathology Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Digital Pathology Platform Sales Value Share by Region (2027-2032) Table 35. Global Digital Pathology Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Digital Pathology Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Digital Pathology Platform Sales Value Market Share by Country (2021-2026) Table 38. Global Digital Pathology Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Digital Pathology Platform Sales Value Market Share by Country (2027-2032) Table 40. Leica Biosystems Company Information Table 41. Leica Biosystems Business Overview Table 42. Leica Biosystems Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Leica Biosystems Digital Pathology Platform Product Portfolio Table 44. Leica Biosystems Recent Development Table 45. Olympus Company Information Table 46. Olympus Business Overview Table 47. Olympus Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Olympus Digital Pathology Platform Product Portfolio Table 49. Olympus Recent Development Table 50. Philips Company Information Table 51. Philips Business Overview Table 52. Philips Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Philips Digital Pathology Platform Product Portfolio Table 54. Philips Recent Development Table 55. Roche Company Information Table 56. Roche Business Overview Table 57. Roche Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Roche Digital Pathology Platform Product Portfolio Table 59. Roche Recent Development Table 60. 3DHISTECH Company Information Table 61. 3DHISTECH Business Overview Table 62. 3DHISTECH Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. 3DHISTECH Digital Pathology Platform Product Portfolio Table 64. 3DHISTECH Recent Development Table 65. Hamamatsu Photonics Company Information Table 66. Hamamatsu Photonics Business Overview Table 67. Hamamatsu Photonics Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Hamamatsu Photonics Digital Pathology Platform Product Portfolio Table 69. Hamamatsu Photonics Recent Development Table 70. ZEISS Company Information Table 71. ZEISS Business Overview Table 72. ZEISS Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. ZEISS Digital Pathology Platform Product Portfolio Table 74. ZEISS Recent Development Table 75. OptraScan Company Information Table 76. OptraScan Business Overview Table 77. OptraScan Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. OptraScan Digital Pathology Platform Product Portfolio Table 79. OptraScan Recent Development Table 80. Media Cyber​​netics Company Information Table 81. Media Cyber​​netics Business Overview Table 82. Media Cyber​​netics Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Media Cyber​​netics Digital Pathology Platform Product Portfolio Table 84. Media Cyber​​netics Recent Development Table 85. Visiopharm Company Information Table 86. Visiopharm Business Overview Table 87. Visiopharm Digital Pathology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Visiopharm Digital Pathology Platform Product Portfolio Table 89. Visiopharm Recent Development Table 90. Sectra Company Information Table 91. Sectra Business Overview Table 92. Sectra Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Sectra Digital Pathology Platform Product Portfolio Table 94. Sectra Recent Development Table 95. Digital Slide Archive Company Information Table 96. Digital Slide Archive Business Overview Table 97. Digital Slide Archive Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Digital Slide Archive Digital Pathology Platform Product Portfolio Table 99. Digital Slide Archive Recent Development Table 100. Aiforia Company Information Table 101. Aiforia Business Overview Table 102. Aiforia Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Aiforia Digital Pathology Platform Product Portfolio Table 104. Aiforia Recent Development Table 105. PathAI Company Information Table 106. PathAI Business Overview Table 107. PathAI Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. PathAI Digital Pathology Platform Product Portfolio Table 109. PathAI Recent Development Table 110. Pathomation Company Information Table 111. Pathomation Business Overview Table 112. Pathomation Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Pathomation Digital Pathology Platform Product Portfolio Table 114. Pathomation Recent Development Table 115. Proscia Company Information Table 116. Proscia Business Overview Table 117. Proscia Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Proscia Digital Pathology Platform Product Portfolio Table 119. Proscia Recent Development Table 120. Indica Labs Company Information Table 121. Indica Labs Business Overview Table 122. Indica Labs Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Indica Labs Digital Pathology Platform Product Portfolio Table 124. Indica Labs Recent Development Table 125. Gestalt Company Information Table 126. Gestalt Business Overview Table 127. Gestalt Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Gestalt Digital Pathology Platform Product Portfolio Table 129. Gestalt Recent Development Table 130. Xybion Company Information Table 131. Xybion Business Overview Table 132. Xybion Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Xybion Digital Pathology Platform Product Portfolio Table 134. Xybion Recent Development Table 135. NovoPath Company Information Table 136. NovoPath Business Overview Table 137. NovoPath Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. NovoPath Digital Pathology Platform Product Portfolio Table 139. NovoPath Recent Development Table 140. Glencoe Software Company Information Table 141. Glencoe Software Business Overview Table 142. Glencoe Software Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Glencoe Software Digital Pathology Platform Product Portfolio Table 144. Glencoe Software Recent Development Table 145. Orbit Image Analysis Company Information Table 146. Orbit Image Analysis Business Overview Table 147. Orbit Image Analysis Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Orbit Image Analysis Digital Pathology Platform Product Portfolio Table 149. Orbit Image Analysis Recent Development Table 150. Augmentiqs Company Information Table 151. Augmentiqs Business Overview Table 152. Augmentiqs Digital Pathology Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Augmentiqs Digital Pathology Platform Product Portfolio Table 154. Augmentiqs Recent Development Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Digital Pathology Platform Product Image Figure 2. Global Digital Pathology Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Pathology Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Pathology Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Open-Source Platforms Image Figure 8. Closed-Source Platforms Image Figure 9. Global Digital Pathology Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Digital Pathology Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Digital Pathology Platform Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Image Figure 13. Clinical Use Image Figure 14. Research Image Figure 15. Education Image Figure 16. Global Digital Pathology Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Digital Pathology Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Digital Pathology Platform Sales Value Share by Application (2021-2032) Figure 19. Global Digital Pathology Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Digital Pathology Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Digital Pathology Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Digital Pathology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Digital Pathology Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Digital Pathology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Digital Pathology Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Digital Pathology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Digital Pathology Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Digital Pathology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Digital Pathology Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Digital Pathology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Digital Pathology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Open-Source Platforms
  • Closed-Source Platforms
Applications
  • Pharmaceutical
  • Clinical Use
  • Research
  • Education
Companies covered
  • Leica Biosystems
  • Olympus
  • Philips
  • Roche
  • 3DHISTECH
  • Hamamatsu Photonics
  • ZEISS
  • OptraScan
  • Media Cyber​​netics
  • Visiopharm
  • Sectra
  • Digital Slide Archive
  • Aiforia
  • PathAI
  • Pathomation
  • Proscia
  • Indica Labs
  • Gestalt
  • Xybion
  • NovoPath
  • Glencoe Software
  • Orbit Image Analysis
  • Augmentiqs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Pathology Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Pathology Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Pathology Platform Market Dynamics
  1. 2.1 Digital Pathology Platform Industry Trends
  2. 2.2 Digital Pathology Platform Industry Drivers
  3. 2.3 Digital Pathology Platform Industry Opportunities and Challenges
  4. 2.4 Digital Pathology Platform Industry Restraints
3 Digital Pathology Platform Market by Company
  1. 3.1 Global Digital Pathology Platform Company Revenue Ranking in 2025
  2. 3.2 Global Digital Pathology Platform Revenue by Company (2021-2026)
  3. 3.3 Global Digital Pathology Platform Company Ranking (2024-2026)
  4. 3.4 Global Digital Pathology Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Pathology Platform Company Product Type and Application
  6. 3.6 Global Digital Pathology Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Pathology Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Pathology Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Pathology Platform Market by Type
  1. 4.1 Digital Pathology Platform Type Introduction
  2. 4.1.1 Open-Source Platforms
  3. 4.1.2 Closed-Source Platforms
  4. 4.2 Global Digital Pathology Platform Sales Value by Type
  5. 4.2.1 Global Digital Pathology Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Digital Pathology Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Digital Pathology Platform Sales Value Share by Type (2021-2032)
5 Digital Pathology Platform Market by Application
  1. 5.1 Digital Pathology Platform Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Clinical Use
  4. 5.1.3 Research
  5. 5.1.4 Education
  6. 5.2 Global Digital Pathology Platform Sales Value by Application
  7. 5.2.1 Global Digital Pathology Platform Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Digital Pathology Platform Sales Value by Application (2021-2032)
  9. 5.2.3 Global Digital Pathology Platform Sales Value Share by Application (2021-2032)
6 Digital Pathology Platform Regional Value Analysis
  1. 6.1 Global Digital Pathology Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Pathology Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Pathology Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Pathology Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Pathology Platform Sales Value (2021-2032)
  7. 6.3.2 North America Digital Pathology Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Pathology Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Pathology Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Pathology Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Pathology Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Pathology Platform Sales Value (2021-2032)
  16. 6.6.2 South America Digital Pathology Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Pathology Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Pathology Platform Sales Value Share by Country, 2025 VS 2032
7 Digital Pathology Platform Country-level Value Analysis
  1. 7.1 Global Digital Pathology Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Pathology Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Pathology Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Pathology Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Pathology Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Pathology Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Pathology Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Leica Biosystems
  2. 8.1.1 Leica Biosystems Company Information
  3. 8.1.2 Leica Biosystems Business Overview
  4. 8.1.3 Leica Biosystems Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Leica Biosystems Digital Pathology Platform Product Portfolio
  6. 8.1.5 Leica Biosystems Recent Developments
  7. 8.2 Olympus
  8. 8.2.1 Olympus Company Information
  9. 8.2.2 Olympus Business Overview
  10. 8.2.3 Olympus Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Olympus Digital Pathology Platform Product Portfolio
  12. 8.2.5 Olympus Recent Developments
  13. 8.3 Philips
  14. 8.3.1 Philips Company Information
  15. 8.3.2 Philips Business Overview
  16. 8.3.3 Philips Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Philips Digital Pathology Platform Product Portfolio
  18. 8.3.5 Philips Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Digital Pathology Platform Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 3DHISTECH
  26. 8.5.1 3DHISTECH Company Information
  27. 8.5.2 3DHISTECH Business Overview
  28. 8.5.3 3DHISTECH Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 3DHISTECH Digital Pathology Platform Product Portfolio
  30. 8.5.5 3DHISTECH Recent Developments
  31. 8.6 Hamamatsu Photonics
  32. 8.6.1 Hamamatsu Photonics Company Information
  33. 8.6.2 Hamamatsu Photonics Business Overview
  34. 8.6.3 Hamamatsu Photonics Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hamamatsu Photonics Digital Pathology Platform Product Portfolio
  36. 8.6.5 Hamamatsu Photonics Recent Developments
  37. 8.7 ZEISS
  38. 8.7.1 ZEISS Company Information
  39. 8.7.2 ZEISS Business Overview
  40. 8.7.3 ZEISS Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ZEISS Digital Pathology Platform Product Portfolio
  42. 8.7.5 ZEISS Recent Developments
  43. 8.8 OptraScan
  44. 8.8.1 OptraScan Company Information
  45. 8.8.2 OptraScan Business Overview
  46. 8.8.3 OptraScan Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 OptraScan Digital Pathology Platform Product Portfolio
  48. 8.8.5 OptraScan Recent Developments
  49. 8.9 Media Cyber​​netics
  50. 8.9.1 Media Cyber​​netics Company Information
  51. 8.9.2 Media Cyber​​netics Business Overview
  52. 8.9.3 Media Cyber​​netics Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Media Cyber​​netics Digital Pathology Platform Product Portfolio
  54. 8.9.5 Media Cyber​​netics Recent Developments
  55. 8.10 Visiopharm
  56. 8.10.1 Visiopharm Company Information
  57. 8.10.2 Visiopharm Business Overview
  58. 8.10.3 Visiopharm Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Visiopharm Digital Pathology Platform Product Portfolio
  60. 8.10.5 Visiopharm Recent Developments
  61. 8.11 Sectra
  62. 8.11.1 Sectra Company Information
  63. 8.11.2 Sectra Business Overview
  64. 8.11.3 Sectra Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sectra Digital Pathology Platform Product Portfolio
  66. 8.11.5 Sectra Recent Developments
  67. 8.12 Digital Slide Archive
  68. 8.12.1 Digital Slide Archive Company Information
  69. 8.12.2 Digital Slide Archive Business Overview
  70. 8.12.3 Digital Slide Archive Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Digital Slide Archive Digital Pathology Platform Product Portfolio
  72. 8.12.5 Digital Slide Archive Recent Developments
  73. 8.13 Aiforia
  74. 8.13.1 Aiforia Company Information
  75. 8.13.2 Aiforia Business Overview
  76. 8.13.3 Aiforia Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aiforia Digital Pathology Platform Product Portfolio
  78. 8.13.5 Aiforia Recent Developments
  79. 8.14 PathAI
  80. 8.14.1 PathAI Company Information
  81. 8.14.2 PathAI Business Overview
  82. 8.14.3 PathAI Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 PathAI Digital Pathology Platform Product Portfolio
  84. 8.14.5 PathAI Recent Developments
  85. 8.15 Pathomation
  86. 8.15.1 Pathomation Company Information
  87. 8.15.2 Pathomation Business Overview
  88. 8.15.3 Pathomation Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Pathomation Digital Pathology Platform Product Portfolio
  90. 8.15.5 Pathomation Recent Developments
  91. 8.16 Proscia
  92. 8.16.1 Proscia Company Information
  93. 8.16.2 Proscia Business Overview
  94. 8.16.3 Proscia Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Proscia Digital Pathology Platform Product Portfolio
  96. 8.16.5 Proscia Recent Developments
  97. 8.17 Indica Labs
  98. 8.17.1 Indica Labs Company Information
  99. 8.17.2 Indica Labs Business Overview
  100. 8.17.3 Indica Labs Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Indica Labs Digital Pathology Platform Product Portfolio
  102. 8.17.5 Indica Labs Recent Developments
  103. 8.18 Gestalt
  104. 8.18.1 Gestalt Company Information
  105. 8.18.2 Gestalt Business Overview
  106. 8.18.3 Gestalt Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Gestalt Digital Pathology Platform Product Portfolio
  108. 8.18.5 Gestalt Recent Developments
  109. 8.19 Xybion
  110. 8.19.1 Xybion Company Information
  111. 8.19.2 Xybion Business Overview
  112. 8.19.3 Xybion Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Xybion Digital Pathology Platform Product Portfolio
  114. 8.19.5 Xybion Recent Developments
  115. 8.20 NovoPath
  116. 8.20.1 NovoPath Company Information
  117. 8.20.2 NovoPath Business Overview
  118. 8.20.3 NovoPath Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  119. 8.20.4 NovoPath Digital Pathology Platform Product Portfolio
  120. 8.20.5 NovoPath Recent Developments
  121. 8.21 Glencoe Software
  122. 8.21.1 Glencoe Software Company Information
  123. 8.21.2 Glencoe Software Business Overview
  124. 8.21.3 Glencoe Software Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Glencoe Software Digital Pathology Platform Product Portfolio
  126. 8.21.5 Glencoe Software Recent Developments
  127. 8.22 Orbit Image Analysis
  128. 8.22.1 Orbit Image Analysis Company Information
  129. 8.22.2 Orbit Image Analysis Business Overview
  130. 8.22.3 Orbit Image Analysis Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Orbit Image Analysis Digital Pathology Platform Product Portfolio
  132. 8.22.5 Orbit Image Analysis Recent Developments
  133. 8.23 Augmentiqs
  134. 8.23.1 Augmentiqs Company Information
  135. 8.23.2 Augmentiqs Business Overview
  136. 8.23.3 Augmentiqs Digital Pathology Platform Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Augmentiqs Digital Pathology Platform Product Portfolio
  138. 8.23.5 Augmentiqs Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst